These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 18259943)

  • 1. The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines.
    Soto-Cruz I; Rangel-Corona R; Valle-Mendiola A; Moreno-Morales X; Santiago-Pérez R; Weiss-Steider B; Cáceres-Cortés JR
    Cancer Invest; 2008 Mar; 26(2):136-44. PubMed ID: 18259943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
    Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel actions of tyrphostin AG 879: inhibition of RAF-1 and HER-2 expression combined with strong antitumoral effects on breast cancer cells.
    Larsson LI
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2624-31. PubMed ID: 15526167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
    Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
    J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
    Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
    Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
    Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone.
    Sotomayor S; Carmena MJ; Schally AV; Varga JL; Sánchez-Chapado M; Prieto JC; Bajo AM
    Int J Oncol; 2007 Nov; 31(5):1223-30. PubMed ID: 17912451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer.
    Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
    Hong RL; Spohn WH; Hung MC
    Clin Cancer Res; 1999 Jul; 5(7):1884-91. PubMed ID: 10430096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
    Chen KT; Lin JD; Liou MJ; Weng HF; Chang CA; Chan EC
    Cancer Lett; 2006 Jan; 231(2):192-205. PubMed ID: 16126335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Levitzki R; Chaouat M; Shlomai Z; Klein BY; Kleinberger-Doron N; Gazit A; Tsvieli R; Levitzki A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1442-57. PubMed ID: 10454524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
    Girón RA; Montaño LF; Escobar ML; López-Marure R
    FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin augments proliferation of breast cancer cells via transactivation of HER2.
    Soma D; Kitayama J; Yamashita H; Miyato H; Ishikawa M; Nagawa H
    J Surg Res; 2008 Sep; 149(1):9-14. PubMed ID: 18262553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.